MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Institutional) - Abbott Vascular; Terumo Medical Corporation; SMT
• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; Opsense; Daiichi-Sankyo/Elil Lilly and Company